RSS-Feed abonnieren
DOI: 10.1055/s-0029-1217329
An Improved Synthesis of Resorcylic Acid Macrolactone Inhibitors of Hsp90
Publikationsverlauf
Publikationsdatum:
02. Juni 2009 (online)
Abstract
A synthesis of resorcylic acid macrolactone analogues of the natural product radicicol is described in which the key steps are the acylation and ring opening of a homophthalic anhydride to give an isocoumarin, followed by a ring-closing metathesis to form the macrocycle.
Key words
macrocyclic lactones - isocoumarins - ring-closing metathesis reaction
- 1
Pearl LH.Prodromou C. Annu. Rev. Biochem. 2006, 75: 271 - 2
Pearl LH.Prodromou C.Workman P. Biochem. J. 2008, 410: 439 - 3
Workman P. Cancer Lett. 2004, 206: 149 - 4
Hanahan D.Weinberg RA. Cell 2000, 100: 57 - 5
Powers MV.Workman P. FEBS Lett. 2007, 581: 3758 - 6
Bishop SC.Burlison JA.Blagg BSJ. Curr. Cancer Drug Targets 2007, 7: 369 - 7
Solit DB.Chiosis G. Drug Discovery Today 2008, 13: 38 - 8
Taldone T.Gozman A.Maharaj R.Chiosis G. Curr. Opin. Pharm. 2008, 8: 370 - 9
Drysdale MJ.Brough PA. Curr. Top. Med. Chem. 2008, 8: 859 - 10
Taldone T.Sun W.Chiosis G. Bioorg. Med. Chem. 2009, 17: 2225 - 11
Prodromou C.Roe SM.O’Brien R.Ladbury JE.Piper PW.Pearl LH. Cell 1997, 90: 65 - 12
Roe SM.Prodromou C.O’Brien R.Ladbury JE.Piper PW.Pearl LH. J. Med. Chem. 1999, 42: 260 - 13
Dehner A.Furrer J.Richter K.Schuster I.Buchner J.Kessler H. ChemBioChem 2003, 4: 870 - 14
Ali MMU.Roe SM.Vaughan CK.Meyer P.Panaretou B.Piper PW.Prodromou C.Pearl LH. Nature (London) 2006, 440: 1013 - 15
Delmotte P.Delmotteplaquee J. Nature (London) 1953, 171: 344 - 16
Winssinger N.Barluenga S. Chem. Commun. 2007, 22 - 17
Barluenga S.Dakas PY.Boulifa M.Moulin E.Winssinger N. C. R. Chim. 2008, 11: 1306 - 18
Hofmann T.Altmann KH. C. R. Chim. 2008, 11: 1318 - 19
Lampilas M.Lett R. Tetrahedron Lett. 1992, 33: 773 - 20
Lampilas M.Lett R. Tetrahedron Lett. 1992, 33: 777 - 21
Tichkowsky I.Lett R. Tetrahedron Lett. 2002, 43: 3997 - 22
Tichkowsky I.Lett R. Tetrahedron Lett. 2002, 43: 4003 - 23
Garbaccio RM.Stachel SJ.Baeschlin DK.Danishefsky SJ. J. Am. Chem. Soc. 2001, 123: 10903 - 24
Barluenga S.Moulin E.Lopez P.Winssinger N. Chem. Eur. J. 2005, 11: 4935 - 25
Proisy N.Sharp SY.Boxall K.Connelly S.Roe SM.Prodromou C.Slawin AMZ.Pearl LH.Workman P.Moody CJ. Chem. Biol. 2006, 13: 1203 - 26
Yang ZQ.Geng XD.Solit D.Pratilas CA.Rosen N.Danishefsky SJ. J. Am. Chem. Soc. 2004, 126: 7881 - 27
Barluenga S.Lopez P.Moulin E.Winssinger N. Angew. Chem. Int. Ed. 2004, 43: 3467 - 28
Cooper TS.Atrash B.Sheldrake P.Workman P.McDonald E. Tetrahedron Lett. 2006, 47: 2241 - 29
Bauta WE.Lovett DP.Cantrell WR.Burke BD.
J. Org. Chem. 2003, 68: 5967 - 30
Shair MD.Yoon TY.Mosny KK.Chou TC.Danishefsky SJ. J. Am. Chem. Soc. 1996, 118: 9509 - 32
Shimamoto T.Chimori M.Sogawa H.Yamamoto K.
J. Am. Chem. Soc. 2005, 127: 16410
References and Notes
5-Chloro-6,8-bis(methoxymethoxy)isochroman-1,3-dione
(8)
Mp 96-98 ˚C. MS: m/z calcd for C13H13
³5ClNaO7:
339.0242; found: 339.0229 [M + Na]. IR
(CH2Cl2): νmax = 1796,
1756, 1593 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 7.18 (1 H,
s, ArH), 5.48 (2 H, s, OCH2O), 5.39 (2 H, s, OCH2O),
4.20 (2 H, s, CH2), 3.53 (3 H, s, OCH3), 3.52
(3 H, s, OCH3). ¹³C NMR
(100 MHz, acetone-d
6): δ = 165.3
(C), 160.6 (C), 159.2 (C), 157.1 (C), 137.7 (C), 114.6 (C), 107.1
(C), 103.4 (CH), 96.3 (CH2), 96.1 (C), 57.0 (CH3),
56.9 (CH3), 34.2 (CH2). ESI-MS: m/z (%) = 341/339
(23/69) [M + Na], 327 (14),
309 (15).
Ethyl 2-[5-Chloro-6,8-bis(methoxymethoxy)-1-oxo-1
H
-isochromen-3-yl]hept-6-enoate
(13)
Mp 50-52 ˚C. MS: m/z calcd for C22H27
³5ClNaO8:
477.1292; found: 477.1326 [M + Na]. IR
(CH2Cl2): νmax = 2987,
1736, 1661, 1585 cm-¹. ¹H
NMR (400 MHz, acetone-d
6):
δ = 7.15 (1 H, s, ArH), 6.85 (1 H, s, ArH), 5.89-5.77
(1 H, m, CH=CH2), 5.45 (2 H, s, OCH2O),
5.34 (2 H, s, OCH2O), 5.05-4.93 (2 H, m, CH=CH2),
4.18 (2 H, q, J = 7.1 Hz, CO2CH2CH3),
3.66 (1 H, t, J = 7.5 Hz, CHCH2),
3.51 (3 H, s, OCH3), 3.51 (3 H, s, OCH3),
2.13 (2 H, dt, J = 7.1, 7.5
Hz, CH2), 2.00-1.89 (2 H, m, CH2),
1.49 (2 H, quin, J = 7.1, CH2),
1.22 (2 H, q, J = 7.1 Hz, CO2CH2CH3). ¹³C
NMR (100 MHz, CDCl3): δ = 171.1 (C),
160.5 (C), 159.2 (C), 157.2 (C), 158.15 (C), 139.1 (CH), 138.6 (C),
115.3 (CH2), 110.9 (C), 105.9 (C), 103.7 (CH), 101.2
(CH), 96.4 (CH2), 96.0 (CH2), 61.8 (CH2),
56.9 (CH3), 56.8 (CH3), 50.5 (CH), 34.0 (CH2),
27.2 (CH2), 14.5 (CH3), 1 × CH2 unobserved.
ESI-MS: m/z (%) = 475/477
(36/100) [M + Na].
(
E
)-1-Chloro-2,4-dihydroxy-7,8,11,12,13,14-hexahydro-6-oxa-16
H
-benzocyclotetradecene-5,15-dione
(3)
Mp 174-176 ˚C (lit.²5 mp
168-169 ˚C). MS: m/z calcd
for C17H19
³5ClNaO5:
361.0813; found: 361.0817 [M + Na]. IR (CH2Cl2): νmax = 3722,
3156, 1712, 1659, 1603 cm-¹. ¹H NMR
(300 MHz, CDCl3): δ = 11.80 (1 H, s,
OH), 6.61 (1 H, s, ArH), 6.17 (1 H, s, OH), 5.56-5.39 (2
H, m, CH=CH), 4.44 (2 H, t, J = 5.3
Hz, CO2CH2), 4.29 (2 H, s, CH2),
2.58 (2 H, t, J = 6.5 Hz, CH2),
2.44 (2 H, dt, J = 5.3, 5.3
Hz, CH2), 2.10 (2 H, dt, J = 6.2,
4.8 Hz, CH2), 1.71 (2 H, quin, J = 6.2 Hz,
CH2), 1.58 (2 H, m, CH2). ¹³C
NMR (75 MHz, CDCl3): δ = 206.2 (C),
170.7 (C), 163.0 (C), 156.4 (C), 136.2 (CH), 134.1 (C), 126.8 (C),
114.7 (C), 107.3 (CH), 65.8 (CH2), 46.8 (CH2),
41.0 (CH2), 32.2 (CH2), 31.54 (CH2),
25.5 (CH2), 22.1 (CH2). ESI-MS: m/z (%) = 363/361
(31/100) [M + Na], 341/339
(4/12).
(
E
)-1-Chloro-2,4-dihydroxy-7,8,11,12,13,14-hexahydro-8-methyl-6-oxa-16
H
-benzocyclotetradecene-5,15-dione (17)
Mp
163-164 ˚C. MS: m/z calcd
for C18H21
³5ClNaO5: 375.0970;
found: 375.0959 [M + Na]. IR (CH2Cl2): νmax = 3686,
3512, 1720, 1658, 1604 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 11.78 (1
H, s, OH), 6.63 (1 H, s, ArH), 6.00 (1 H, br s, OH), 5.46 (1 H,
dt, J = 15.6, 7.5 Hz, =CH),
5.34 (1 H, dt, J = 15.6, 7.3
Hz, =CH), 4.27 (1 H, dd, J = 10.7,
3.0 Hz, CO2CH), 4.28 (2 H, s, CH2), 3.99 (1
H, t, J = 10.7 Hz, CO2CH),
2.58 (3 H, m, CH2, CH), 2.13 (3 H, m, CH2,
CH), 1.72 (3 H, m, CH2, CH), 1.04 (3 H, d, J = 7.0 Hz, CH3). ¹³C NMR
(125 MHz, CDCl3): δ = 205.7 (C), 171.8
(C), 163.8 (C), 158.9 (C), 138.3 (C), 134.3 (CH), 132.5 (CH), 115.9 (C),
107.8 (C), 103.6 (CH), 71.1 (CH2), 47.1 (CH2),
41.2 (CH2), 36.7 (CH), 32.7 (CH2), 26.6 (CH2),
23.0 (CH2), 17.4 (CH3). ESI-MS: m/z (%) = 377/375
(33/100) [M + Na], 355/353
(8/23), 335/337 (31/10).
Crystallographic data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB21EZ, UK; fax: +44 (1223)336033; or deposit@ccdc.cam.ac.uk].